{"id":"https://openalex.org/W2409971208","doi":null,"title":"A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group.","display_name":"A comparison of two dose levels of granisetron in patients receiving high-dose cisplatin. The Granisetron Study Group.","alternate_titles":[],"publication_year":1990,"publication_date":"1990-01-01","ids":{"openalex":"https://openalex.org/W2409971208","mag":"2409971208","pmid":"https://pubmed.ncbi.nlm.nih.gov/2169779"},"language":"en","primary_location":{"id":"pmid:2169779","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2169779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Clinical Trial"},"parent_works":[],"lineage":["https://openalex.org/W2409971208"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5017156620","display_name":"Mike Soukop","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800666604","display_name":"Glasgow Royal Infirmary","ror":"https://ror.org/00bjck208","country_code":"GB","type":"healthcare","lineage":["https://openalex.org/I2800201399","https://openalex.org/I2800666604"]}],"countries":["GB"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"M Soukop","raw_affiliation_strings":["Department of Medical Oncology, Royal Infirmary, Glasgow, U.K"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medical Oncology, Royal Infirmary, Glasgow, U.K","institution_ids":["https://openalex.org/I2800666604"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5017156620"],"corresponding_institution_ids":["https://openalex.org/I2800666604"],"apc_list":null,"apc_paid":null,"fwci":7.2286,"has_fulltext":false,"cited_by_count":51,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.97012636,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":87,"max":95},"biblio":{"volume":"26 Suppl 1","issue":null,"first_page":"S15","last_page":"S19"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11785","display_name":"Nausea and vomiting management","score":1.0,"subfield":{"id":"https://openalex.org/subfields/2746","display_name":"Surgery"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12429","display_name":"Chemotherapy-induced organ toxicity mitigation","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3005","display_name":"Toxicology"},"field":{"id":"https://openalex.org/fields/30","display_name":"Pharmacology, Toxicology and Pharmaceutics"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11964","display_name":"Pregnancy and Medication Impact","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2739","display_name":"Public Health, Environmental and Occupational Health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/granisetron","display_name":"granisetron","score":1.0},{"id":"https://openalex.org/keywords/cisplatin","display_name":"cisplatin","score":0.8069999814033508},{"id":"https://openalex.org/keywords/high-dose-chemotherapy","display_name":"high-dose chemotherapy","score":0.8320000171661377},{"id":"https://openalex.org/keywords/antiemetic-efficacy","display_name":"antiemetic efficacy","score":0.7509999871253967},{"id":"https://openalex.org/keywords/nausea-and-vomiting","display_name":"nausea and vomiting","score":0.7720000147819519},{"id":"https://openalex.org/keywords/dose-comparison","display_name":"dose comparison","score":0.7829999923706055},{"id":"https://openalex.org/keywords/headache-adverse-event","display_name":"headache adverse event","score":0.6460000276565552},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.5040000081062317}],"concepts":[{"id":"https://openalex.org/C2777452722","wikidata":"https://www.wikidata.org/wiki/Q596708","display_name":"Granisetron","level":4,"score":0.9966477155685425},{"id":"https://openalex.org/C2780580376","wikidata":"https://www.wikidata.org/wiki/Q186889","display_name":"Nausea","level":2,"score":0.8875672221183777},{"id":"https://openalex.org/C2780852908","wikidata":"https://www.wikidata.org/wiki/Q127076","display_name":"Vomiting","level":2,"score":0.860668420791626},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.7971649169921875},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.6814769506454468},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.6488297581672668},{"id":"https://openalex.org/C2778239845","wikidata":"https://www.wikidata.org/wiki/Q412415","display_name":"Cisplatin","level":3,"score":0.6024271249771118},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.5864691734313965},{"id":"https://openalex.org/C2780884295","wikidata":"https://www.wikidata.org/wiki/Q575136","display_name":"Antiemetic","level":3,"score":0.376350462436676},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.31065618991851807},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.20931196212768555}],"mesh":[{"descriptor_ui":"D002945","descriptor_name":"Cisplatin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D007191","descriptor_name":"Indazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009325","descriptor_name":"Nausea","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":false},{"descriptor_ui":"D009369","descriptor_name":"Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D012702","descriptor_name":"Serotonin Antagonists","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D013997","descriptor_name":"Time Factors","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000139","qualifier_name":"chemically induced","is_major_topic":false},{"descriptor_ui":"D014839","descriptor_name":"Vomiting","qualifier_ui":"Q000517","qualifier_name":"prevention & control","is_major_topic":true},{"descriptor_ui":"D017829","descriptor_name":"Granisetron","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"pmid:2169779","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2169779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of cancer (Oxford, England : 1990)","raw_type":"Clinical Trial"},{"id":"mag:2409971208","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/2169779","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":null,"is_accepted":false,"is_published":false,"raw_source_name":"PubMed","raw_type":null}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3","score":0.9940000176429749}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2138524596","https://openalex.org/W243857094","https://openalex.org/W77070658","https://openalex.org/W2053746953","https://openalex.org/W2126516096","https://openalex.org/W2034199439","https://openalex.org/W2405517119","https://openalex.org/W1537122182","https://openalex.org/W1487053004","https://openalex.org/W2413914637"],"abstract_inverted_index":{"In":[0,37,149],"this":[1,152],"double-blind":[2],"study,":[3],"the":[4,38,67,90,98,104,118,130,134],"efficacy":[5,114],"and":[6,24,43,51,75,101],"safety":[7,116],"of":[8,45,60,83,87,95,121,133,147],"a":[9],"novel":[10],"anti-emetic,":[11],"granisetron,":[12],"was":[13,123,126,142],"assessed":[14],"at":[15],"two":[16,119],"dose":[17,131],"levels":[18],"(40":[19,62],"micrograms/kg;":[20,26],"n":[21,27],"=":[22,28],"149":[23],"160":[25],"147)":[29],"in":[30,66,79,85,97,103,113,145],"296":[31],"patients":[32,96],"undergoing":[33],"high-dose":[34],"cisplatin":[35],"chemotherapy.":[36],"first":[39,68],"24":[40,69],"h,":[41],"57%":[42],"60%":[44],"patients,":[46],"respectively,":[47],"experienced":[48],"no":[49,52,107],"vomiting":[50],"more":[53],"than":[54],"mild":[55],"nausea.":[56],"Two":[57],"further":[58],"doses":[59,120],"granisetron":[61,122],"micrograms/kg)":[63],"were":[64],"permitted":[65],"h":[70],"to":[71,157],"treat":[72],"breakthrough":[73],"nausea":[74],"vomiting.":[76],"This":[77],"resulted":[78],"resolution":[80],"or":[81,115,155],"improvement":[82],"symptoms":[84],"68-89%":[86],"patients.":[88,148],"Over":[89],"7-day":[91],"study":[92,135],"period,":[93],"53%":[94],"lower-dose":[99],"group":[100],"51%":[102],"higher":[105],"received":[106],"conventional":[108],"anti-emetic":[109],"therapy.":[110],"No":[111],"difference":[112],"between":[117],"established.":[124],"Granisetron":[125],"well":[127],"tolerated":[128],"throughout":[129],"range":[132],"(40-240":[136],"micrograms/kg).":[137],"The":[138],"commonest":[139],"adverse":[140],"event":[141],"headache,":[143],"seen":[144],"13-16%":[146],"all":[150],"cases":[151],"resolved":[153],"spontaneously":[154],"responded":[156],"simple":[158],"treatment.":[159]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2409971208","counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2012,"cited_by_count":1}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
